OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AU25         View EO 12866 Meetings	Received Date: 06/22/2020
Title: Request for Information; Electronic Prescribing for Controlled Substances (CMS-3394)
Agency/Subagency: HHS / CMS	Stage: Notice
Concluded Action: Consistent with Change	Concluded Date: 07/27/2020
Legal Deadline: None	Economically Significant: No
Publication Date: 08/04/2020	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No